title: Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab.
authors: Departments of Dermatology.
authors: Takashi
authors: T
authors: Anan
authors: Plastic Surgery, Faculty of Medicine, Oita University, Oita, Japan.
authors: Fumiaki
authors: F
authors: Shimizu
authors: Departments of Dermatology.
authors: Yutaka
authors: Y
authors: Hatano
authors: Departments of Dermatology.
authors: Osamu
authors: O
authors: Okamoto
authors: Departments of Dermatology.
authors: Kazumoto
authors: K
authors: Katagiri
authors: Departments of Dermatology.
authors: Sakuhei
authors: S
authors: Fujiwara
mesh_terms: D000368:Aged; D060487:Alternariosis / Q000150:complications / Q000628:therapy; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D057112:Corneal Perforation / Q000150:complications / Q000628:therapy; D003881:Dermatomycoses / Q000150:complications / Q000628:therapy; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications; D010257:Paraneoplastic Syndromes / Q000150:complications* / Q000473:pathology / Q000628:therapy; D059545:Paraneoplastic Syndromes, Ocular / Q000150:complications / Q000473:pathology / Q000628:therapy; D010392:Pemphigus / Q000150:complications* / Q000473:pathology / Q000628:therapy; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab